The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Coffee and tea consumption and the risk of Parkinson's disease
Abstract
Several prospective studies have assessed the association between coffee consumption and Parkinson's disease (PD) risk, but the results are inconsistent. We examined the association of coffee and tea consumption with the risk of incident PD among 29,335 Finnish subjects aged 25 to 74 years without a history of PD at baseline. During a mean follow‐up of 12.9 years, 102 men and 98 women developed an incident PD. The multivariate‐adjusted (age, body mass index, systolic blood pressure, total cholesterol, education, leisure‐time physical activity, smoking, alcohol and tea consumption, and history of diabetes) hazard ratios (HRs) of PD associated with the amount of coffee consumed daily (0, 1–4, and ≥5 cups) were 1.00, 0.55, and 0.41 (P for trend = 0.063) in men, 1.00, 0.50, and 0.39 (P for trend = 0.073) in women, and 1.00, 0.53, and 0.40 (P for trend = 0.005) in men and women combined (adjusted also for sex), respectively. In both sexes combined, the multivariate‐adjusted HRs of PD for subjects drinking ≥3 cups of tea daily compared with tea nondrinkers was 0.41 (95% CI 0.20–0.83). These results suggest that coffee drinking is associated with a lower risk of PD. More tea drinking is associated with a lower risk of PD. © 2007 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
(1970) · Cited by 24,983
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., & Schwartz, P. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014868 · Cited by 15,289
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
STAI manual for the State-trait anxiety inventory
Cd, S. (1970) · Medical Entomology and Zoology · Cited by 2,433
Wiklund, R. A., & Rosenbaum, S. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371606 · Cited by 2,149
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Nehlig, A., Daval, J.-L., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,461
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
Chiba, K., Trevor, A., & Castagnoli, N. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91293-2 · Cited by 1,097
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Environmental risk factors and Parkinson's disease: A case‐control study in Taiwan
Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., & Chen, R. C. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616
Neuroprotection by Caffeine and A2AAdenosine Receptor Inactivation in a Model of Parkinson's Disease
Chen, J.-F., Xu, K., Petzer, J. P., Staal, R., Xu, Y.-H., Beilstein, M., Sonsalla, P. K., Castagnoli, K., Castagnoli, N., & Schwarzschild, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-j0001.2001 · Cited by 606
Moghaddam, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13387.x · Cited by 567
Protection against ionizing radiation by antioxidant nutrients and phytochemicals
Weiss, J. F., & Landauer, M. R. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00149-5 · Cited by 562
Type 2 Diabetes and the Risk of Parkinson's Disease
Hu, G., Jousilahti, P., Bidel, S., Antikainen, R., & Tuomilehto, J. (2007) · Diabetes Care · doi:10.2337/dc06-2011 · Cited by 466
Self-citationCardiovascular risk factor changes in Finland, 1972–1997
Vartiainen, E., Jousilahti, P., Alfthan, G., Sundvall, J., Pietinen, P., & Puska, P. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.1.49 · Cited by 401
Self-citationHu, G., Barengo, N. C., Tuomilehto, J., Lakka, T. A., Nissinen, A., & Jousilahti, P. (2004) · Hypertension · doi:10.1161/01.hyp.0000107400.72456.19 · Cited by 394
Self-citationHu, G., Qiao, Q., Silventoinen, K., Eriksson, J. G., Jousilahti, P., Lindström, J., Valle, T. T., Nissinen, A., & Tuomilehto, J. (2003) · Diabetologia · doi:10.1007/s00125-003-1031-x · Cited by 381
Self-citationOxidative stress and antioxidant therapy in Parkinson's disease
Ebadi, M., Srinivasan, S. K., & Baxi, M. D. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00029-1 · Cited by 336
HU, G., TUOMILEHTO, J., SILVENTOINEN, K., BARENGO, N., & JOUSILAHTI, P. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.10.020 · Cited by 322
Self-citationWeight loss in Parkinson's disease
Chen, H., Zhang, S. M., Hernán, M. A., Willett, W. C., & Ascherio, A. (2003) · Annals of Neurology · doi:10.1002/ana.10577 · Cited by 297
Coffee Consumption and Risk of Type 2 Diabetes Mellitus Among Middle-aged Finnish Men and Women
Tuomilehto, J. (2004) · JAMA · doi:10.1001/jama.291.10.1213 · Cited by 281
Self-citationFamilial Aggregation of Parkinson's Disease in Iceland
Sveinbjörnsdóttir, S., Hicks, A. A., Jónsson, T., Pétursson, H., Guðmundsson, G., Frigge, M. L., Kong, A., Gulcher, J. R., & Stefánsson, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432404 · Cited by 275
Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes
Hu, G., Jousilahti, P., Barengo, N. C., Qiao, Q., Lakka, T. A., & Tuomilehto, J. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.799 · Cited by 265
Self-citationLeisure time, occupational, and commuting physical activity and the risk of stroke
Hu, G., Sarti, C., Jousilahti, P., Silventoinen, K., Barengo, N. C., & Tuomilehto, J. (2005) · Stroke · doi:10.1161/01.str.0000177868.89946.0c · Cited by 258
Self-citationHu, G., Eriksson, J., Barengo, N. C., Lakka, T. A., Valle, T. T., Nissinen, A., Jousilahti, P., & Tuomilehto, J. (2004) · Circulation · doi:10.1161/01.cir.0000138102.23783.94 · Cited by 252
Self-citationDietary Antioxidants and Parkinson Disease: The Rotterdam Study
de Rijk, M. C. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550180070015 · Cited by 250
Bosch, J. A., de Geus, E. J. C., Veerman, E. C. I., Hoogstraten, J., & Nieuw Amerongen, A. V. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000058376.50240.2d · Cited by 248
Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease
Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003) · Neurology · doi:10.1212/01.wnl.0000046523.05125.87 · Cited by 234
Ascherio, A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh312 · Cited by 232
Pająk, A., Kuulasmaa, K., Tuomilehto, J. O., & Ruokokoski, E. (1988) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 230
Self-citationYokogoshi, H., Kobayashi, M., Mochizuki, M., & Terashima, T. (1998) · Neurochemical Research · doi:10.1023/a:1022490806093 · Cited by 229
Body mass index and the risk of Parkinson disease
Hu, G., Jousilahti, P., Nissinen, A., Antikainen, R., Kivipelto, M., & Tuomilehto, J. (2006) · Neurology · doi:10.1212/01.wnl.0000247052.18422.e5 · Cited by 203
Self-citationYokogoshi, H., Kato, Y., Sagesaka, Y. M., Takihara-Matsuura, T., Kakuda, T., & Takeuchi, N. (1995) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.59.615 · Cited by 192
Medicinal Benefits of Green Tea: Part II. Review of Anticancer Properties
Cooper, R., Morré, D. J., & Morré, D. M. (2005) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2005.11.639 · Cited by 187
Secretory immunoglobulin A and cardiovascular reactions to mental arithmetic and cold pressor
Willemsen, G. A. H. M., Ring, C., Carroll, D., EVANS, P., Clow, A., & Hucklebridge, F. H. (1998) · Psychophysiology · doi:10.1017/s0048577298970421 · Cited by 165
Occupational Metal Exposures and the Risk of Parkinson’s Disease
Gorell, J. M., Rybicki, B. A., Johnson, C. C., & Peterson, E. L. (1999) · Neuroepidemiology · doi:10.1159/000026225 · Cited by 150
Cardiovascular reactivity and the course of immune response to an acute psychological stressor.
Herbert, T. B., Cohen, S., Marsland, A. L., Bachen, E. A., Rabin, B. S., Muldoon, M. F., & Manuck, S. B. (1994) · Psychosomatic Medicine · doi:10.1097/00006842-199407000-00009 · Cited by 143
Inhibition of Azoxymethane‐induced Colon Carcinogenesis in Rat by Green Tea Polyphenol Fraction
Yamane, T., Hagiwara, N., Tateishi, M., Akachi, S., Kim, M., Okuzumi, J., Kitao, Y., Inagake, M., Kuwata, K., & Takahashi, T. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01801.x · Cited by 143
Hu, G., Tuomilehto, J., Borodulin, K., & Jousilahti, P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl475 · Cited by 141
Self-citationKAKUDA, T., NOZAWA, A., SUGIMOTO, A., & NIINO, H. (2002) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.66.2683 · Cited by 131 · cited 3×
“Although the affinity of L-Theanine with the glutamate receptors was remarkably lower than the L-glutamic one (about 80–30,000 fold less), there have been several reports indicating the functional role of L-Theanine, such as a neuroprotective effect in cortical neurons via the antagonistic role with glutamate receptor…”
Inhibiting effects of theanine on caffeine stimulation evaluated by EEG in the rat
KAKUDA, T., NOZAWA, A., UNNO, T., OKAMURA, N., & OKAI, O. (2000) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.64.287 · Cited by 131
Lymphocyte subset and cellular immune responses to a brief experimental stressor.
Bachen, E. A., Manuck, S. B., Marsland, A. L., Cohen, S., Malkoff, S. B., Muldoon, M. F., & Rabin, B. S. (1992) · Psychosomatic Medicine · doi:10.1097/00006842-199211000-00007 · Cited by 130
Ring, C., Harrison, L. K., Winzer, A., Carroll, D., Drayson, M. T., & Kendall, M. J. (2000) · Psychophysiology · doi:10.1017/s0048577200991030 · Cited by 127
Occupational Metal Exposures and the Risk of Parkinson’s Disease
Raterman, K. (2011) · Cited by 124
Vascular parkinsonism--an important cause of parkinsonism in older people
Thanvi, B., Lo, N., & Robinson, T. (2005) · Age and Ageing · doi:10.1093/ageing/afi025 · Cited by 124
Effects of L-Theanine on the Release of .ALPHA.-Brain Waves in Human Volunteers.
KOBAYASHI, K., NAGATO, Y., AOI, N., JUNEJA, L. R., KIM, M., YAMAMOTO, T., & SUGIMOTO, S. (1998) · Journal of the agricultural chemical society of Japan · doi:10.1271/nogeikagaku1924.72.153 · Cited by 123
TERASHIMA, T., TAKIDO, J., & YOKOGOSHI, H. (1999) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.63.615 · Cited by 112
Differential effects of active versus passive coping on secretory immunity
Bosch, J. A., de Geus, E. J. C., Kelder, A., Veerman, E. C. I., Hoogstraten, J., & Amerongen, A. V. N. (2001) · Psychophysiology · doi:10.1111/1469-8986.3850836 · Cited by 109
Bidel, S., Hu, G., Qiao, Q., Jousilahti, P., Antikainen, R., & Tuomilehto, J. (2006) · Diabetologia · doi:10.1007/s00125-006-0435-9 · Cited by 107
Self-citationAdenosine A2A receptors modify motor function in MPTP-treated common marmosets
Kanda, T., Tashiro, T., Kuwana, Y., & Jenner, P. G. (1998) · Neuroreport · doi:10.1097/00001756-199808240-00032 · Cited by 102
Atanackovic, D., Atanackovic, D., Brunner-Weinzierl, M. C., Kröger, H., Serke, S., & Deter, H. (2002) · Immunological Investigations · doi:10.1081/imm-120004800 · Cited by 98
Alcohol consumption and the incidence of Parkinson's disease
Hernán, M. Á., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2003) · Annals of Neurology · doi:10.1002/ana.10611 · Cited by 87
Willemsen, G. A. H. M., Carroll, D., Ring, C., & Drayson, M. T. (2002) · Psychophysiology · doi:10.1111/1469-8986.3920222 · Cited by 86
Reactivity of immune, endocrine and cardiovascular parameters to active and passive acute stress
Isowa, T., Ohira, H., & Murashima, S. (2003) · Biological Psychology · doi:10.1016/s0301-0511(03)00115-7 · Cited by 84
Theanine-induced reduction of brain serotonin concentration in rats
YOKOGOSHI, H., MOCHIZUKI, M., & SAITOH, K. (1998) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.62.816 · Cited by 83
Hu, G., Jousilahti, P., Peltonen, M., Bidel, S., & Tuomilehto, J. O. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803341 · Cited by 74
Self-citationWillemsen, G., Ring, C., McKeever, S., & Carroll, D. (2000) · Biological Psychology · doi:10.1016/s0301-0511(99)00028-9 · Cited by 71
Carpenter, G. H., Proctor, G., Anderson, L. C., Zhang, X. S., & Garrett, J. R. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.01968.x · Cited by 69
Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from Tobacco
Castagnoli, K., Steyn, S. J., Petzer, J. P., der Schyf, C. J. V., & Castagnoli, N. J. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000224v · Cited by 57
Breznitz, S., Ben‐Zur, H., Berzon, Y., Weiss, D. W., Levitan, G., Tarcic, N., Lischinsky, S., Greenberg, A., Levi, N., & Zinder, O. (1998) · Brain Behavior and Immunity · doi:10.1006/brbi.1997.0511 · Cited by 52
Effect of theanine on norepinephrine and serotonin levels in rat brain
KIMURA, R., & MURATA, T. (1986) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.34.3053 · Cited by 51
Temporal variation of acute stress responses in sympathetic nervous and immune systems
Kimura, K., Isowa, T., Ohira, H., & Murashima, S. (2005) · Biological Psychology · doi:10.1016/j.biopsycho.2004.12.006 · Cited by 51
Possible involvement of group I mGluRs in neuroprotective effect of theanine
Nagasawa, K., Aoki, H., Yasuda, E., Nagai, K., Shimohama, S., & Fujimoto, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.143 · Cited by 48
Mutagenicity test of food additives with Salmonella typhimurium TA97 and TA102 (V)
Fujita, H., & SASAKI, M. (1990) · Cited by 47
Vieregge, P., Hagenah, J., Heberlein, I., Klein, C., & Ludin, H. P. (1999) · Neurology · doi:10.1212/wnl.53.3.566 · Cited by 36
Development and validation of Japanese version of State-Trait Anxiety Inventory
Nakazato, K. (1982) · Medical Entomology and Zoology · Cited by 35
Mutagenecity test of food additives with Salmonella typhimurium TA97 and TA102.
Fujita, H. (1993) · Medical Entomology and Zoology · Cited by 25
Cited by
The epidemiology of Parkinson's disease: risk factors and prevention
Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,825
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Coffee and its Consumption: Benefits and Risks
Butt, M. S., & Sultan, M. T. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903586412 · Cited by 612
Maiti, P., Manna, J., & Dunbar, G. L. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0099-z · Cited by 525
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428
Self-citation
Metadata
- Authors
- Hu, G., Bidel, S., Jousilahti, P., Antikainen, R., & Tuomilehto, J.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2007-08-21
- Volume
- 22
- Issue
- 15
- Pages
- 2242-2248
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2145334223
- Cited by
- 280
- References
- 72
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.